This Government Contract opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Medical Supply Manufacturer or Distributor

Closed

Federal

Submission Closed05/26/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411

SLED

U.S.-Manufactured Water Pipe and Fittings SupplyThe contract involves the supply of 12-inch PVC water pipes and related fittings that must comply with U.S. manufacturing standards under the Buy American provisions. It is issued as a subcontract by the City of High Shoals, North Carolina, targeting compliance with NAICS code 325411, which pertains to the manufacture of chemical products relevant to the materials required. The solicitation was posted on June 8, 2026, with a response deadline set for July 7, 2026, providing a clear timeline for vendors interested in participating. The procurement emphasizes adherence to domestic manufacturing requirements, ensuring that the materials supplied support U.S. industry. Although specific details such as the solicitation number, point of contact, and exact location for performance were not provided, the contract is accessible via the North Carolina electronic procurement portal, which serves as the platform for submission and further information. This arrangement indicates a focus on locally sourced materials for municipal infrastructure projects and compliance with federal procurement standards.

POSTED

DEADLINE

Raw Material and API SupplyThis contract involves the supply of FDA-approved active pharmaceutical ingredients (APIs) and excipients essential for the formulation of finished dosage pharmaceutical products. It is designated as a subcontract under the Raw Material and API Supply title with an emphasis on materials compliant with regulatory standards to ensure quality and safety in drug production. The contract falls under the NAICS code 325411, which pertains to pharmaceutical preparation manufacturing. The contracting agency is the Department of Veterans Affairs, operating through the Nac Federal Supply Schedule (36F797), indicating that the supplied materials will support healthcare initiatives for veterans. Although specific details such as location, point of contact, and set-aside classifications are not provided, the primary focus remains on securing reliable raw materials to facilitate ongoing pharmaceutical manufacturing processes for the agency's healthcare programs.

Nac Federal Supply Schedule (36F797)

POSTED

DEADLINE

Active Pharmaceutical Ingredient (API) SupplyThis contract involves the procurement of bulk active pharmaceutical ingredients (APIs) that are essential for final drug formulation. These ingredients are typically obtained from third-party manufacturers who comply with current Good Manufacturing Practices (cGMP), ensuring high quality and safety standards. The contract is a subcontract under the Nac Federal Supply Schedule (36F797) facilitated by the Department of Veterans Affairs, aiming to supply APIs that support various pharmaceutical needs. While specific details such as solicitation number, exact location for performance, and point of contact are not provided, the contract is classified under the NAICS code 325411, which pertains to pharmaceutical preparation manufacturing. The acquisition under this contract is critical to maintaining a reliable supply chain for drug production, reflecting the government's commitment to sourcing compliant and quality-active ingredients for healthcare applications.

Nac Federal Supply Schedule (36F797)

POSTED

DEADLINE

PharmacyThis contract, identified as 2025-AAP-GSU-SU-0009, pertains to the procurement of pharmaceuticals under the title "Pharmacy" and falls within the NAICS code 325411, which relates to pharmaceutical preparation manufacturing. It is managed by the Indian Health Service, an agency focused on providing healthcare services to American Indian and Alaska Native populations. The contract is currently in the forecast stage as of March 11, 2026, indicating planned or expected solicitation activities, though the solicitation number and type of set-aside are not specified. Key points include the contact information for both the program point of contact, Maryjo Zunic, and the contracting officer, Misty Billy, who holds responsibility for the contract management. While specifics such as place of performance and detailed terms are not provided, the contract opportunity is accessible via the OSDBU industry opportunity forecast platform. This contract is likely aimed at ensuring the supply of pharmaceutical products essential for the health services provided by the Indian Health Service.

Indian Health Service

POSTED

DEADLINE

PharmaceuticalThe contract pertains to pharmaceutical products and is managed by the Indian Health Service, with a focus on providing medical supplies related to the pharmaceutical industry classified under NAICS code 325411. It was posted on March 11, 2026, as a forecast opportunity, indicating anticipated future contracting needs rather than an active solicitation. Specific details such as the solicitation number, set-aside status, location of performance, and organization type are not provided, suggesting flexibility in potential awardees and delivery locations. Key contacts for this contract include Gabriella Janke, serving as the program point of contact, and Misty Billy, the contracting officer overseeing the procurement process. Interested parties can reach out via the provided email addresses for more information or clarification. The contract opportunity is accessible through the Office of Small and Disadvantaged Business Utilization's industry forecast platform, providing transparency and outreach to potential vendors in the pharmaceutical sector.

Indian Health Service

POSTED

22 days ago

DEADLINE

N/A

AI Contract Overview

The contract involves the manufacture or supply of 20 units of Biofreeze Analgesic Gel, each container holding 4 ounces with a 5% Menthol USP concentration. The product must fully comply with FDA regulations, Good Manufacturing Practices (GMP), labeling standards, and Defense Logistics Agency (DLA) specifications. This procurement is categorized under NAICS code 325411, which relates to pharmaceutical manufacturing. The contracting agency is the Department of Defense, specifically through the Medical Supply Chain Pharmacy Field Support Activity, with performance expected at Fort Bragg, zip code 28310. The opportunity was posted on May 18, 2026, and responses are due by May 26, 2026. This is a subcontracting opportunity aimed at manufacturers or distributors capable of meeting stringent regulatory and supply standards for medical analgesic products.

General Info

Supply 20 Biofreeze gels, 4oz 5% Menthol, FDA/GMP compliant, Dept. of Defense subcontract.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325411 - Medicinal and Botanical Manufacturing View NAICS

Place of Performance

FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 18

subcontract

Response DeadlineMay 26

Deadline has passed

Submission Closed

05/26/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressN/A

ContactsNo contact information available

Full Description

Manufacture or supply of 20 units of Biofreeze Analgesic Gel (4 oz, 5% Menthol USP) compliant with FDA, GMP, labeling, and DLA specifications.